Update app.py
Browse files
app.py
CHANGED
@@ -1050,32 +1050,32 @@ with gr.Blocks() as app:
|
|
1050 |
<tr>
|
1051 |
<td>History and Examination</td>
|
1052 |
<td>10 mins</td>
|
1053 |
-
<td>
|
1054 |
</tr>
|
1055 |
<tr>
|
1056 |
<td>Path Sample Processing time</td>
|
1057 |
<td>30 mins</td>
|
1058 |
-
<td>
|
1059 |
</tr>
|
1060 |
<tr>
|
1061 |
<td>Path sample reporting time</td>
|
1062 |
<td>30 mins</td>
|
1063 |
-
<td>
|
1064 |
</tr>
|
1065 |
<tr>
|
1066 |
<td>Colposcopy</td>
|
1067 |
<td>25 mins</td>
|
1068 |
-
<td>
|
1069 |
</tr>
|
1070 |
<tr>
|
1071 |
<td>Thermal Ablation</td>
|
1072 |
<td>25 mins</td>
|
1073 |
-
<td>
|
1074 |
</tr>
|
1075 |
<tr>
|
1076 |
<td>Hysterectomy</td>
|
1077 |
<td>50 mins</td>
|
1078 |
-
<td>
|
1079 |
</tr>
|
1080 |
<tr>
|
1081 |
<th>Epidemiological Parameters</th>
|
@@ -1083,27 +1083,27 @@ with gr.Blocks() as app:
|
|
1083 |
<tr>
|
1084 |
<td>Screen positivity</td>
|
1085 |
<td>10 %</td>
|
1086 |
-
<td>
|
1087 |
</tr>
|
1088 |
<tr>
|
1089 |
<td>Biopsy positivity rate</td>
|
1090 |
<td>40%</td>
|
1091 |
-
<
|
1092 |
</tr>
|
1093 |
<tr>
|
1094 |
<td>Biopsy CIN Ratio</td>
|
1095 |
<td>60%</td>
|
1096 |
-
<td>
|
1097 |
</tr>
|
1098 |
<tr>
|
1099 |
<td>Biopsy CaCx Ratio</td>
|
1100 |
<td>2 %</td>
|
1101 |
-
<td>
|
1102 |
</tr>
|
1103 |
<tr>
|
1104 |
<td>Follow up rate after positive screen</td>
|
1105 |
<td>65 %</td>
|
1106 |
-
<td>
|
1107 |
</tr>
|
1108 |
<tr>
|
1109 |
<th>Hospital Resources</th>
|
|
|
1050 |
<tr>
|
1051 |
<td>History and Examination</td>
|
1052 |
<td>10 mins</td>
|
1053 |
+
<td>Expert opinion of core modelling group</td>
|
1054 |
</tr>
|
1055 |
<tr>
|
1056 |
<td>Path Sample Processing time</td>
|
1057 |
<td>30 mins</td>
|
1058 |
+
<td>Expert opinion of core modelling group</td>
|
1059 |
</tr>
|
1060 |
<tr>
|
1061 |
<td>Path sample reporting time</td>
|
1062 |
<td>30 mins</td>
|
1063 |
+
<td>Asamani et al (2024)</td>
|
1064 |
</tr>
|
1065 |
<tr>
|
1066 |
<td>Colposcopy</td>
|
1067 |
<td>25 mins</td>
|
1068 |
+
<td>Asamani et al (2024)</td>
|
1069 |
</tr>
|
1070 |
<tr>
|
1071 |
<td>Thermal Ablation</td>
|
1072 |
<td>25 mins</td>
|
1073 |
+
<td>Asamani et al (2024)</td>
|
1074 |
</tr>
|
1075 |
<tr>
|
1076 |
<td>Hysterectomy</td>
|
1077 |
<td>50 mins</td>
|
1078 |
+
<td>Asamani et al (2024)</td>
|
1079 |
</tr>
|
1080 |
<tr>
|
1081 |
<th>Epidemiological Parameters</th>
|
|
|
1083 |
<tr>
|
1084 |
<td>Screen positivity</td>
|
1085 |
<td>10 %</td>
|
1086 |
+
<td>Expert opinion of core modelling group</td>
|
1087 |
</tr>
|
1088 |
<tr>
|
1089 |
<td>Biopsy positivity rate</td>
|
1090 |
<td>40%</td>
|
1091 |
+
<tdExpert opinion of core modelling group</td>
|
1092 |
</tr>
|
1093 |
<tr>
|
1094 |
<td>Biopsy CIN Ratio</td>
|
1095 |
<td>60%</td>
|
1096 |
+
<td>Expert opinion of core modelling group</td>
|
1097 |
</tr>
|
1098 |
<tr>
|
1099 |
<td>Biopsy CaCx Ratio</td>
|
1100 |
<td>2 %</td>
|
1101 |
+
<td>Expert opinion of core modelling group</td>
|
1102 |
</tr>
|
1103 |
<tr>
|
1104 |
<td>Follow up rate after positive screen</td>
|
1105 |
<td>65 %</td>
|
1106 |
+
<td>Expert opinion of core modelling group</td>
|
1107 |
</tr>
|
1108 |
<tr>
|
1109 |
<th>Hospital Resources</th>
|